A Pill For COVID? Molnupiravir, Explained calendar_today October 3rd, 2021 Listen On iTunesListen On SpotifyWatch The Video Promising early results for an oral therapeutic for SARS-CoV2. Here’s what we know and what it may mean. Here’s the topline data from Merck so far. Video with transcript here Subscribe to Podcast Tags Big Pharma Cardiology Infectious Diseases Molnupiravir Neurology Pediatrics Pfizer COVID Vaccine Rheumatology The ZDoggMD Show Vaccines